Hemostatic Disorders: Clinical Trials

59 trials for Hemostatic Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

59 unknown. 59 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable59Unknown 59

Follow Hemostatic Disorders: new trials by email Literature Review of Hemostatic Disorders trials Research Report on Hemostatic Disorders

Trials (filtered) newest first · largest first

All 59 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pre-hospital Administration of Fibrinogen in Trauma-Induced Coagulopathy
Fibrinogen concentrate, Standard trauma care - Trauma Induced Coagulopathy
Not applicableUnknownUnidade Local de Saude do Arco Ribeirinho522025-01-012024-09-19
Evaluation of the Effects of Cross Linking on the Biomechanical Characteristics of Skin Samples From Patients With Classic or Hypermobile Ehlers-Danlos Syndrome
skin biopsy - Ehlers-Danlos Syndrome
Not applicableUnknownGCS Ramsay Santé pour l'Enseignement et la Recherche282024-09-032024-06-24
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
Topical Product: Almond Oil, Topical Product: Almond oil augmented with 0.5% Vitamin E, Topical Product: 0.025% Tretinoin oil augmented with castor oil - Collagen Degeneration, Wrinkle
Not applicableUnknownIntegrative Skin Science and Research902024-07-222024-08-28
Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves
NeuroTears, Placebo - Dry Eye Disease, Dry Eye
Not applicableUnknownGenetic Disease Investigators752024-04-012024-02-21
RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders
Gut-directed hypnotherapy, Standard Medical Therapy - Ehlers-Danlos Syndrome, Irritable Bowel Syndrome
Not applicableUnknownUniversity Health Network, Toronto742024-04-012024-03-22
Efficacy and Safety Evaluation of PD1-BCMA-CART
PD1-BCMA-CART - Multiple Myeloma
Not applicableUnknownBioray Laboratories92024-03-012024-01-05
LI-TASTE Study: Light for Taste
LX2.3 Laser and LED Photobiomodulation System, LX2.3 Laser and LED Photobiomodulation System Sham-PBMT Setting - Multiple Myeloma
Not applicableUnknownAcademic Centre for Dentistry in Amsterdam522024-02-292024-02-14
A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM
Bortezomib - Multiple Myeloma, Renal Injury
Not applicableUnknownPeking University First Hospital302024-01-022024-01-12
The Effects of Almond on Facial Skin Collagen and Wrinkles
Food: whole almonds, Food: non-nut snack - Collagen Degeneration, Wrinkle
Not applicableUnknownIntegrative Skin Science and Research602023-10-042024-06-18
Cyclin D1 as a Prognostic Factor in Multiple Myeloma and Its Association With the Immunological Prognostic Factor PDL1 and Clinical and Biochemical Lab Tests
Bone marow biopsy and aspiration, biochemical and heamatological tests - Multiple Myeloma
Not applicableUnknownSohag University302023-09-012023-08-16
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
CT0594CP - Multiple Myeloma, Plasma Cell Leukemia
Not applicableUnknownThe First Affiliated Hospital of Soochow University62023-04-122023-04-20
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.
Ixazomib DX/Lenalidomide DX - Progression Free Survival, Overall Survival
Not applicableUnknownRenJi Hospital4202023-02-162024-04-15
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
White LED light, Green LED light - Ehlers-Danlos Syndrome, Pain, Chronic
Not applicableUnknownNew York Institute of Technology302022-11-212024-05-06
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
Etoposide, Cytarabine, PEG-rhG-CSF - Lymphoma, Multiple Myeloma
Not applicableUnknownThe Affiliated People's Hospital of Ningbo University682022-11-012024-03-19
Benefits of Adapted Physical Activity for Chronic Osteoarticular Pain in Patients With Multiple Myeloma
adapted physical activity - Multiple Myeloma, Adapted Physical Activity
Not applicableUnknownUniversity Hospital, Caen152022-11-012022-09-21
Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma
Pomalidomide - Multiple Myeloma
Not applicableUnknownLanZhou University152022-05-152023-10-04
Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma
pegylated recombinant human granulocyte-colony stimulating factor - Lymphoma, Multiple Myeloma
Not applicableUnknownYao Liu72022-04-222023-09-29
Early Integration of Palliative and Supportive Care in Cellular Therapy
Early palliative and supportive care - Leukemia, Lymphoma
Not applicableUnknownAlberta Health Services, Calgary1522022-04-082024-07-31
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
18F-PSMA-1007, 18F-FDG - Multiple Myeloma
Not applicableUnknownFirst Hospital of China Medical University302022-03-082022-07-08
In Vitro Drug Sensitivity Testing of Fresh Human Samples
Blood collection for the evaluation of the anti-drugs sensitivity - Myeloproliferative Disorders, Lymphoproliferative Disorders
Not applicableUnknownHospices Civils de Lyon8002022-03-012022-03-17

Showing 20 of 59. Sign in to see all of them.

Narrower conditions

Multiple Myeloma (36)  ·  Ehlers-Danlos Syndrome (9)  ·  Lymphoma (7)  ·  Hematologic Neoplasms (5)  ·  Leukemia (4)  ·  Chronic Pain (3)  ·  Hemorrhage (3)  ·  Hodgkin Disease (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Calcinosis (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Plasma Cell (2)  ·  Myeloproliferative Disorders (2)  ·  Neoplasms, Plasma Cell (2)

Broader conditions

Cardiovascular Diseases (59)  ·  Hemic and Lymphatic Diseases (59)  ·  Hemorrhagic Disorders (59)  ·  Vascular Diseases (59)  ·  Hematologic Diseases (58)  ·  Immune System Diseases (38)  ·  Blood Protein Disorders (36)  ·  Immunoproliferative Disorders (36)  ·  Lymphoproliferative Disorders (36)  ·  Neoplasms (36)  ·  Neoplasms by Histologic Type (36)  ·  Paraproteinemias (36)  ·  Neoplasms, Plasma Cell (34)  ·  Pathological Conditions, Signs and Symptoms (15)

Interventions

Cyclophosphamide (4)  ·  Antilymphocyte Serum (2)  ·  Filgrastim (2)  ·  Melphalan (2)  ·  fludarabine (2)  ·  fludarabine phosphate (2)  ·  pegylated granulocyte colony-stimulating factor (2)  ·  89Zr-bevacizumab (1)  ·  Acupuncture Therapy (1)  ·  Anesthesia, General (1)  ·  Blood Specimen Collection (1)  ·  Bortezomib (1)  ·  Busulfan (1)  ·  Castor Oil (1)  ·  Clostridium perfringens epsilon-toxin (1)

Sponsors

Hebei Senlang Biotechnology Inc., Ltd. (2)  ·  Integrative Skin Science and Research (2)  ·  University Hospital, Angers (2)  ·  Academic Centre for Dentistry in Amsterdam (1)  ·  Alberta Health Services, Calgary (1)  ·  Asan Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  Bioray Laboratories (1)  ·  Cairo University (1)  ·  Central Hospital, Nancy, France (1)  ·  Chen Wenming (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Fairview University Medical Center (1)

Countries

China (15)  ·  United States (8)  ·  France (5)  ·  Canada (3)  ·  Netherlands (3)  ·  Belgium (2)  ·  South Korea (2)  ·  Austria (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  Mexico (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Wenming Chen, doctor (2)  ·  Alexandre Ghuysen, MD, PhD (1)  ·  Annabel Blasi, MD, PhD (1)  ·  Arne Slungaard (1)  ·  Charles A. Linker, MD (1)  ·  Christian F Weber, MD (1)  ·  Claire L Shovlin, PhD FRCP (1)  ·  Fabricio Edler Macagnan, PhD (1)  ·  Francisco Das Neves Coelho, MD (1)  ·  Frederic Lecouvet, MD-PhD (1)  ·  Hans Gombotz, PhD, MD (1)  ·  Hao Zhang (1)  ·  Henning Bay Nielsen, MD (1)  ·  Hira Mian, MD (1)

Results publications

PMID 15894595, PMID 24277820, PMID 24969777, PMID 26586530, PMID 37591523, PMID 39186588, PMID 39377681, PMID 39620223, PMID 40388042, PMID 40569697, PMID 42247107, PMID 42615297